Clinique Even Better Clinical Dark Spot Clearing Serum with Vitamin C, 1.7 fl oz - Brightening and Soothing
Dermatologist-Developed Even Better Clinical Radical Dark Spot Corrector + Interrupter
The Even Better Clinical Radical Dark Spot Corrector + Interrupter by Clinique is a potent brightening serum designed to improve hyperpigmentation and uneven skin tone. It has been developed by dermatologists and is proven to visibly reduce dark spots by 39% in 12 weeks.*
This dark spot corrector contains the CL302 Brightening Complex, known for delivering dramatic brightening results. It is suitable for all skin types, including sensitive skin, and features Clinique’s proprietary brightening molecule to promote a more even skin tone, including reducing acne pigmentation marks.
In addition to vitamin C, this serum also includes salicylic acid and glucosamine to exfoliate surface discoloration, as well as yeast extract to break up excess pigment clusters (dark spots). Within 2.5 hours, it can help reduce redness from irritation that may trigger new visible spots and worsen existing ones.**
Developed for all skin types and tones, from light to melanin-rich, the Even Better Clinical brightening specialists from Clinique provide visible results in reducing hyperpigmentation and creating a more even skin tone.
*Clinical testing conducted on 52 women. **After pre-treatment period; clinical testing on 26 people, measured for 150 minutes, versus untreated control.
Dermatologist-Developed Even Better Clinical Radical Dark Spot Corrector + Interrupter
The Even Better Clinical Radical Dark Spot Corrector + Interrupter by Clinique is a potent brightening serum designed to improve hyperpigmentation and uneven skin tone. It has been developed by dermatologists and is proven to visibly reduce dark spots by 39% in 12 weeks.*
This dark spot corrector contains the CL302 Brightening Complex, known for delivering dramatic brightening results. It is suitable for all skin types, including sensitive skin, and features Clinique’s proprietary brightening molecule to promote a more even skin tone, including reducing acne pigmentation marks.
In addition to vitamin C, this serum also includes salicylic acid and glucosamine to exfoliate surface discoloration, as well as yeast extract to break up excess pigment clusters (dark spots). Within 2.5 hours, it can help reduce redness from irritation that may trigger new visible spots and worsen existing ones.**
Developed for all skin types and tones, from light to melanin-rich, the Even Better Clinical brightening specialists from Clinique provide visible results in reducing hyperpigmentation and creating a more even skin tone.
*Clinical testing conducted on 52 women. **After pre-treatment period; clinical testing on 26 people, measured for 150 minutes, versus untreated control.
Dermatologist-Developed Even Better Clinical Radical Dark Spot Corrector + Interrupter
The Even Better Clinical Radical Dark Spot Corrector + Interrupter by Clinique is a potent brightening serum designed to improve hyperpigmentation and uneven skin tone. It has been developed by dermatologists and is proven to visibly reduce dark spots by 39% in 12 weeks.*
This dark spot corrector contains the CL302 Brightening Complex, known for delivering dramatic brightening results. It is suitable for all skin types, including sensitive skin, and features Clinique’s proprietary brightening molecule to promote a more even skin tone, including reducing acne pigmentation marks.
In addition to vitamin C, this serum also includes salicylic acid and glucosamine to exfoliate surface discoloration, as well as yeast extract to break up excess pigment clusters (dark spots). Within 2.5 hours, it can help reduce redness from irritation that may trigger new visible spots and worsen existing ones.**
Developed for all skin types and tones, from light to melanin-rich, the Even Better Clinical brightening specialists from Clinique provide visible results in reducing hyperpigmentation and creating a more even skin tone.
*Clinical testing conducted on 52 women. **After pre-treatment period; clinical testing on 26 people, measured for 150 minutes, versus untreated control.